A Pharmacovigilance Study of Adverse Drugreactions Report Forms in Dic Of Svcp, Tirupati

Main Article Content

K.Mounika
Mallikarjuna B.P
A.Supriya
B.Vinod Kumar Naik
M.Pavithra
P.Gowthamuni
R.Poojitha
R.Radhika

Abstract

Pharmacovigilance is an important and necessary component of clinical research. Both clinical trial safety and post-marketing surveillance pharmacovigilance are critical throughout the product lifecycle.Pharmacovigilance is defined as "the pharmacological science relating to the detection, assessment, comprehension, and prevention of adverse effects of medicines." In India, pharmacovigilance is still in its infancy, Pharmacovigilance monitors any adverse drug effects.Improve public health and safety in the use of medications.Contribute to the assessment of medicine's benefit, harm, effectiveness, and risk, encouraging safe, rational, and effective use.ADR (Adverse drug reaction) is a noxious and unintended response to a drug that occurs at doses normally used in man for disease prevention, diagnosis, or therapy, or for the modification of physiological function.

Article Details

How to Cite
K.Mounika, Mallikarjuna B.P, A.Supriya, B.Vinod Kumar Naik, M.Pavithra, P.Gowthamuni, R.Poojitha, & R.Radhika. (2023). A Pharmacovigilance Study of Adverse Drugreactions Report Forms in Dic Of Svcp, Tirupati. Journal of Coastal Life Medicine, 11(2), 1471–1480. Retrieved from https://www.jclmm.com/index.php/journal/article/view/1183
Section
Articles

References

Durga Prasad Thammisetty, Deepishka Pemmasani, Sai Deepak Gali, Ramesh Babu Atmakur, Rajalakshmi Rukmangathen, Vasundhara Devi Brahmanapalli, Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati, Perspectives in Clinical Research, 2019, 11(4): 158-163.

Sanket S. Gaidhane, Akash A. Khobragade, Abhijeet Joshi, Monisha S. Chavan, Likith H. V, Akshay A. Chaware, A Pharmacovigilance study in patients of chronic non-infective respiratory diseases attending outpatient department of pulmonary medicine in a tertiary care teaching hospital, International Journal ofBasic and Clinical Pharmacology, 2021,10(6):675-682.

Debasish Misra, Sansita Parida, Manika Bose, Smitha Das, Swati Mishra, Sudhanshu S. Mishra, Adverse cutaneous drug reactions reporting in a tertiary care teaching hospital in Eastern India: a retrospective study, International Journal of Basic and Clinical Pharmacology, 2020, 9(9):1381-1385.

D. Phani Bhushan1, R. Hari Babu, J. Rashi, M. Tabitha Satya Suvidha2, Mounika Susanthi U, T. Sri Lekha, A pharmacovigilance study of anti-depressant agents in psychiatric patients at a tertiary care teaching hospital, International Journal of Research in Medical Sciences, 2020, 8(5):1745-1749.

Sree Sudha TY, Yakaiah Vangoori and Anjali Mary Varghese, A Profile of Adverse Drug Reactions in a Tertiary Care Hospital and Associated Factors, Biomed Pharmocol, 2021,14(1).

Adil Ali Shakur, Sukalyan Saha Roy, Lalit Mohan, Manish Kumar, Hithesh Mishra, Harihar Dikshit, Monish Likithkar, Analysis of reporting adverse drug reactions in a tertiary care hospital: One year survey, IP International Journal of Comprehensive and Advanced Pharmacology, 2020, 5(1):25-30.

Jarin james, Jamuna Rani, A Prospective Study of Adverse drug Reactions in a Tertiary Care Hospital in South India, Asian Journal of Pharmaceutical and Clinical Research, 2022, 13(1):89-92.

Ramadan M Elkalmi, Mohamed Hassan Elnaem, Nurmisaliza Mohd Sapar, Ali Blebil, Assessment of the Reporting of Adverse Drug Reactions in a Malaysian Retrospective Clinical Training Centre: A Short Communication, Journal of Pharmacy and Bio allied Sciences, 2021, 13(3):325-330.

Laila Carolina Abu Esba, Ghada Al Mardawi, Mohammed I AlJasser, Badr Aljohani, Amjed Abu Alburak, Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented, Journal of Clinical Pharmacy and Therapeutics, 2021, 46(2) :460-469.

Baijayanti Rath, Manas Ranjan Naik, Bhabagrahi Rath, Renuka Bhai, Jai Prakash, Cutaneous Adverse Drug Reactions in a tertiary care hospital: An Observational study, Journal of Pharmacovigilance and drug research, 2020,1(1): 6-9.

Sana Parveen Shaik, Rajan nerukar, Adverse drug reaction profile of anticancer agents in a tertiary care hospital: an observational study, Current Drug Safety, 2022, 17(2):136-142.